MicroRNAs in acute leukemia: from biological players to clinical contributors

MicroRNAs (miRNAs) are involved in the management of hematopoiesis. As a consequence, miRNA dysregulation causes disruption of the hematopoietic system and leukemia may arise. We here comprehensively discuss miRNAs found discriminative for cytogenetic and molecular subtypes of acute leukemia. These miRNAs are either known miRNAs involved in leukemogenesis with proven tumor suppressor or oncogenic activities or are newly identified by high-throughput sequencing with yet unknown function. Furthermore, forces are outlined that drive aberrant miRNA function, which include genetic abnormalities (for example, deletions, translocations and mutations) and epigenetic aberrations (for example, aberrant DNA methylation or histone modifications). Interestingly, leukemia-silenced miRNAs can be re-expressed upon treatment with de-methylating agents. Targeting miRNA expression may serve a therapeutical role, albeit at present this way of targeted therapy is in its infancy. However, emerging knowledge about the biology of miRNAs in leukemia may result into a role for these miRNAs in the diagnosis and treatment of acute leukemia.

[1]  K. Basso,et al.  A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. , 2007, Cancer cell.

[2]  M. D. Boer,et al.  Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia , 2011, Leukemia.

[3]  Donglin Cao,et al.  Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia , 2010, Proceedings of the National Academy of Sciences.

[4]  S. Kauppinen,et al.  LNA-mediated microRNA silencing in non-human primates , 2008, Nature.

[5]  C. Croce,et al.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.

[6]  Zhiguo Wang,et al.  The principles of MiRNA-masking antisense oligonucleotides technology. , 2011, Methods in molecular biology.

[7]  C. Pui,et al.  Biology and treatment of acute lymphoblastic leukemia , 1994 .

[8]  M. Cleary,et al.  The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. , 2010, Cancer research.

[9]  S. Papageorgiou,et al.  The role of microRNAs in normal and malignant hematopoiesis , 2010, European journal of haematology.

[10]  Aadel A. Chaudhuri,et al.  Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder , 2008, The Journal of experimental medicine.

[11]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[12]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[13]  R. Siebert,et al.  Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Brown,et al.  The promise of microRNA replacement therapy. , 2010, Cancer research.

[15]  M. Caligiuri,et al.  IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Patrick J. Paddison,et al.  Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia , 2010, Nature Cell Biology.

[17]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[18]  C. Croce Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[19]  Hui Zhou,et al.  Genome-Wide Analysis of Small RNA and Novel MicroRNA Discovery in Human Acute Lymphoblastic Leukemia Based on Extensive Sequencing Approach , 2009, PloS one.

[20]  Torsten Haferlach,et al.  Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin , 2008, Proceedings of the National Academy of Sciences.

[21]  C. Croce,et al.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Cope,et al.  A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells. , 2008, Cancer research.

[23]  Noam Shomron,et al.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 , 2009, Leukemia.

[24]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[25]  Caifu Chen,et al.  MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia , 2011, Haematologica.

[26]  Judy Lieberman,et al.  Promise and Challenge of Rna Interference–based Therapy for Cancer Journal of Clinical Oncology B I O L O G Y O F N E O P L a S I A , 2010 .

[27]  Beiyan Zhou,et al.  MicroRNA miR-125b causes leukemia , 2010, Proceedings of the National Academy of Sciences.

[28]  S. Armstrong,et al.  A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 Acute Lymphocytic Leukemia cells , 2010, Cell cycle.

[29]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[30]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[31]  M. Caligiuri,et al.  Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  G. Ruvkun,et al.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.

[33]  Andrea Califano,et al.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.

[34]  T. Du,et al.  Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.

[35]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[36]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[37]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[39]  T. Dingermann,et al.  The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. , 2010, Blood.

[40]  C. Croce,et al.  MicroRNAs in normal and malignant hematopoiesis , 2008, Current opinion in hematology.

[41]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[42]  Guido Marcucci,et al.  Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. , 2008, Cancer research.

[43]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[44]  S. Armstrong,et al.  miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. , 2008, Blood.

[45]  T Chaplin,et al.  MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis , 2007, Leukemia.

[46]  J. Rowley,et al.  Leukaemogenesis: more than mutant genes , 2010, Nature Reviews Cancer.

[47]  N. Zeleznik-Le,et al.  MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets. , 2010, Current drug targets.

[48]  C. Burge,et al.  Identification of let-7-regulated oncofetal genes. , 2008, Cancer research.

[49]  Liang-Hu Qu,et al.  MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia , 2009, PloS one.

[50]  J. Rowley,et al.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. , 2009, Blood.

[51]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[52]  Wayne Tam,et al.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Xian-Ming Chen,et al.  Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation , 2010, British journal of haematology.

[54]  F. Slack,et al.  The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure , 2008, Cell cycle.

[55]  M. Caligiuri,et al.  Prognostic Importance of MN 1 Transcript Levels , and Biologic Insights From MN 1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia : A Cancer and Leukemia Group B Study , 2009 .

[56]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[57]  Christian Langer,et al.  Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  Beth Israel,et al.  Decision letter: Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010 .

[59]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[60]  Hui Zhang,et al.  MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. , 2010, Cancer cell.

[61]  Yijun Qi,et al.  DNA methylation mediated by a microRNA pathway. , 2010, Molecular cell.

[62]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.

[63]  R. Stam,et al.  Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. , 2010, Blood.

[64]  Patricia Soteropoulos,et al.  MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. , 2007, Cancer research.

[65]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[66]  M. Caligiuri,et al.  miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts , 2010, Cell.

[67]  A. van den Berg,et al.  miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC/miR‐155 expression , 2008, The Journal of pathology.

[68]  R. Yeh,et al.  TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. , 2010, Blood.

[69]  M. Caligiuri,et al.  Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  Scott A. Armstrong,et al.  MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.

[71]  R. Pieters,et al.  Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale , 2011, Leukemia.

[72]  Dominique Leroux,et al.  Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation , 2008, The Journal of experimental medicine.

[73]  R. Siebert,et al.  Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. , 2009, Cancer research.

[74]  George A Calin,et al.  MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.

[75]  R. Arceci Consistent Deregulation of Gene Expression between Human and Murine MLL Rearrangement Leukemias , 2009 .

[76]  S. K. Zaidi,et al.  Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. , 2009, Cancer research.

[77]  Hiroyuki Tagawa,et al.  Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. , 2009, Blood.

[78]  E. Thiel,et al.  The Role of Microrna-196a-1 and Microrna-196b in Acute T-Lymphoblastic Leukemia and Acute Myeloid Leukemia. , 2009 .

[79]  H. Lodish,et al.  MicroRNAs as regulators of mammalian hematopoiesis. , 2005, Seminars in immunology.

[80]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[81]  Bob Löwenberg,et al.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.

[82]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Phillip A Sharp,et al.  MicroRNA sponges: progress and possibilities. , 2010, RNA.

[84]  Ryan D. Morin,et al.  Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. , 2009, Blood.

[85]  Ryan D. Morin,et al.  Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.

[86]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[87]  C. Croce,et al.  MicroRNA 29b functions in acute myeloid leukemia. , 2009, Blood.

[88]  R. Pieters,et al.  Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia , 2012, Pediatric blood & cancer.

[89]  Jean-Baptiste Cazier,et al.  Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia , 2008, PloS one.

[90]  J. Cigudosa,et al.  Genetic and Epigenetic Silencing of microRNA-203 Enhances ABL 1 and BCR-ABL 1 Oncogene Expression , 2008 .

[91]  W. Evans,et al.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. , 2009, The Lancet. Oncology.

[92]  Y. Pekarsky,et al.  CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation , 2010, Leukemia.

[93]  S. Orkin,et al.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.

[94]  T. Golub,et al.  Distinct microRNA expression profiles in acute myeloid leukemia with common translocations , 2008, Proceedings of the National Academy of Sciences.

[95]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[96]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[97]  R. Stam,et al.  Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia , 2010, Haematologica.

[98]  M. D. Boer,et al.  Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia , 2009, Leukemia.

[99]  R. Stam,et al.  Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. , 2009, Blood.